免疫纳米金催化共振散射光谱法测定痕量IgM

用粒径为10 nm的金纳米微粒标记羊抗人免疫球蛋白M（IgM）,制备了IgM的免疫纳米金共振散射光谱探针。在pH4.49的KH2PO4-Na2HPO4缓冲溶液及PEG存在下,金标羊抗人IgM与IgM发生特异性结合生成胶体金免疫复合物,离心分离,获得未反应的金标抗上层清液。以此纳米金标抗作为催化剂,在pH 1.93的盐酸-柠檬酸钠缓冲溶液,催化NH2OH·HCl还原吸附在免疫纳米金表面的金络离子物种（AuCl4-）生成粒径更大的金纳米微粒,导致580 nm 处金纳米微粒的共振散射强度急剧增大。结果表明,随着IgM浓度增大,离心上层液中金标抗降低,I 580 nm线性降低,其△I580 nm与IgM浓度在0.06～4.80 ng· ml-1范围内呈良好的线性关系,其回归方程为ΔI580 nm=14.5cIgM + 1.8,检出限为0.03 ng·ml-1。本法具有灵敏、快速和较高的特异性,用于定量分析人血清中IgM,结果满意。     

磁免疫结合单颗粒模式ICP-MS同时测定乳腺癌病人血清中的CEA与CA15-3

该文合成了氨基修饰的磁性纳米颗粒并将其与癌胚抗原（CEA）一抗和糖类抗原 15-3（CA15-3）一抗偶联用提取靶标生物标志物,羧基功能化上转换纳米颗粒(UCNPs)和氨基功能化二氧化铈-二氧化硅纳米颗粒(CeO2-SiO2NPs)用于标记抗体,由于174Yb和140Ce的瞬态信号频率与UCNPs和CeO2-SiO2NPs浓度直接相关,可利用单颗粒ICP-MS产生的瞬态信号频率定量分析CEA和CA15-3,基于此建立了同时测定乳腺癌病人血清中CEA和CA15-3的单颗粒ICP-MS磁免疫分析方法。结果显示：在优化条件下,CEA和CA15-3分别在0.02~100 ng·mL-1和0.05~50 U·mL-1浓度范围内线性良好,相关系数（r2）分别为0.994 0和0.987 0;以3倍信噪比(S/N=3)计算得CEA和CA15-3的检出限(LOD)分别为0.006 7 ng·mL-1和0.016 7 U·mL-1。采用该方法在3名乳腺癌病人血清中均检出CEA和CA15-3,加标回收率分别为95.2%~98.9%和95.5%~97.2%,相对标准偏差（RSD）分别为3.0%~4.6%和3.4%~4.3%。实验结果与临床使用的化学发光免疫方法结果一致,方法可用于乳腺癌病人血清样品中CEA和CA15-3含量的测定。     

La-phen-邻苯二甲酸混配化合物与DNA作用的共振光散射光谱及分析应用

本文研究了镧的混配物LaL1L2·3H2O(L1为邻苯二甲酸,L2为邻菲咯啉)与DNA作用的共振光散射光谱。加入DNA后,在pH6.5～7.5的范围内,LaL1L2·3H2O在DNA分子表面发生长距离自组装,在470nm处产生了增强的共振光散射峰,其发光强度与DNA的浓度成线性关系。该方法的线性范围为23～1870ng·mL-1,检出限(3σ)为23ng·mL-1,可用于测定纳克级的DNA。     

Ag（I）-EGTA螯合体系共振散射法测定痕量银

在Walpole缓冲介质和十二烷基苯磺酸钠（SDBS）溶液中,Ag（I）与乙二醇-双-（2氨基乙基醚）四乙酸（EGTA）可形成较稳定的无色螯合物微粒,使得体系的共振散射信号增强。该螯合物微粒在313nm处产生1个较强共振散射峰。研究表明,在最佳实验条件下,Ag（I）浓度在5．4×10^-3～2．7μg／mL范围内与共振散射强度△I呈较好的线性关系,检出限为0．17ng／mL。该方法用于废胶片中痕量银的测定,结果较满意。     

原子荧光光谱法测定以磷块岩为原料制备磷酸中的砷

本文利用以水作载流的氢化物发生-原子荧光光谱仪测定了以磷块岩为原料自制的磷酸中的砷（As）。利用硫酸法溶融磷块岩自制出磷酸,优化仪器的工作条件,通过条件实验选择出适用于测定砷所需的盐酸和5% L（+）-抗坏血酸-5% 硫脲的用量。原子荧光光谱法测定结果如下：在0.5 ng·mL-1 ~ 8.0 ng·mL-1浓度范围内线性相关系数R2=0.99996;检出限为0.0018 ng·mL-1,样品的相对标准偏差（RSD）为0.82 %,样品的加标回收率在92.4 % ~ 103.4 %。通过与电感耦合等离子体发射光谱法（ICP-OES）比对,结果一致。     

核酸适体修饰纳米金-钌催化共振散射光谱法测定痕量Pb2+

用铅离子的特异性核酸适体（aptamer）修饰AuRu复合纳米微粒（AuRu的摩尔比为5:1）制备了铅离子的核酸适体纳米探针（AptAuRu）.在pH 7.0的Na2HPO4-NaH2PO4缓冲溶液及85 mmol/L NaCl存在下,AptAuRu纳米探针亦不聚集. 当Pb2+ 存在时,Pb2+可与探针中的aptamer形成较稳定的G-四分体结构,从而析放出AuRu复合纳米微粒并进一步聚集形成较大的微粒,导致592 nm处的共振散射光强度线性增大. 该反应液经0.15 μm滤膜过滤后,获得未反应的AptAuRu滤液. 滤液中的纳米微粒对氯酸钠-碘化钠反应具有较强的催化作用,其产物与阳离子表面活性剂形成缔合微粒,在472 nm处有一较强的共振散射峰. 随着Pb2+浓度增大,滤液中金钌纳米微粒浓度降低,其催化作用减弱,共振散射强度值降低. Pb2+浓度在0.12～60 pM范围与其共振散射强度降低值ΔI472nm呈线性关系,回归方程、相关系数分别为ΔI472nm =3.1C+7.3,0.9967, 检出限为0.08 pM Pb2+. 将本法用于废水中Pb2+的检测,其结果令人满意.     

阿特拉津与DNA作用共振光散射光谱的研究及其应用

首次报道了阿特拉津与ctDNA作用的共振光散射光谱 (RLS)特征和利用小分子农药阿特拉津作为探针测定痕量脱氧核糖核酸的方法。在 pH=1.41的酸度条件下 ,阿特拉津 -ctDNA在319.8nm处有一增强的共振光散射光谱峰 ,且增强的共振光散射强度与ctDNA的浓度成线性关系。在实验确定的优化条件下 ,方法的线性范围为0.05～34μg·mL -1 ,检出限为11.9ng·mL -1(3δ) ,该方法成功地用于人工混合样品中ctDNA的测定     

Bi(Ⅲ)-茜素红-CTMAB体系共振散射光谱法测定环境水样中痕量铋

在pH=4.1的HCl溶液中,Bi(Ⅲ)与茜素红和十六烷基三甲基溴化铵（CTMAB）缔合形成粒径较大的疏水性三元离子缔合物（结合比为n(Bi(Ⅲ))∶n(AR)∶n(CTMAB)=1∶3∶3）,该反应导致共振光散射显著增强,最大散射峰位于364 nm。 研究了反应介质、pH值、共振探针浓度等对散射体系的影响,考察了该散射反应的稳定性及共存物质的影响,并对该三元离子缔合物的反应机理进行了探讨。 在2.5 mL 1.0×10-4 mol/L茜素红和2.0 mL 1.0×10-4 mol/L CTMAB最优试验条件下,Bi(Ⅲ)质量浓度与共振光散射强度ΔI364 nm在0～0.384 mg/L范围内呈良好线性关系,检测限为5.898×10-8 g/L,对含量为0.18 mg/L Bi(Ⅲ)溶液进行11次平行测定,其相对标准偏差为2.2%。 将该方法用于环境水样中痕量铋(质量浓度为0.552～0.831 μg/L)的测定,加标回收率为99.5%～100.2%,测定偏差小于2.7%。 基于Bi(Ⅲ)-AR-CTMAB三元离子缔合物的共振光散射光谱,建立了以茜素红染料为光谱探针的痕量Bi(Ⅲ)共振光散射检测新方法。     

大肠杆菌的共振散射光谱研究

研究了大肠杆菌的共振散射光谱.它在470nm、510nm和730nm产生三个瑞利散射峰.当激发波长为470nm(6.38×1014Hz)时,大肠杆菌溶液在470nm(6.38×1014Hz)和940nm(1/2×6.38×1014Hz)分别产生一个瑞利散射峰和一个1/2分频散射峰;当激发波长为510nm(5.88×1014Hz)时,在510nm产生一个共振散射峰;当激发波长为730nm(4.11×1014Hz)时在365nm(2×4.11×1014Hz)和730nm(4.11×1014Hz)分别产生一个2倍频散射峰和一个共振散射峰.分频散射和倍频散峰与共振散射峰具有相似的散射行为.大肠杆菌的浓度在0.074～38×108个/mL范围内与共振光散射强度I470nm、I510nm、I730nm成良好线性关系.     

卤代荧光素与西布曲明相互作用的共振散射光谱特征及其分析应用

利用共振瑞利散射法,研究了乙基曙红、赤鲜红和荧光桃红3种卤代荧光素与盐酸西布曲明的相互作用,发现这3种卤代荧光素与盐酸西布曲明形成了离子缔合物,产生强烈的共振瑞利散射信号,其最大散射峰分别位于316、573和370nm;考察了适宜的反应条件及共存物质的影响,在一定范围内盐酸西布曲明的浓度与共振瑞利散射强度成正比,其线性范围分别是0．1～4．2mg·L^-1（乙基曙红-盐酸西布曲明体系）、0．09-6．0mg·L^-1（赤鲜红-盐酸西布曲明体系）、0．06～3．0mg·L^-1（荧光桃红-盐酸西布曲明体系）,其检出限分别为32、28和21μg·L^-1;在赤鲜红-盐酸西布曲明体系中,573nm处的共振散射光谱偏振度P为0．95,表明体系的共振散射光谱主要由散射光构成。     

免疫纳米金催化氯金酸与羟胺反应-共振散射光谱检测痕量青霉素G

小粒径的金和免疫金纳米粒子对氯金酸-盐酸羟胺这一反应具有较强的催化作用,其产物在580 nm处有一共振散射峰。以半抗原青霉素G为模型,用粒径为9 nm的金纳米微粒标记羊抗兔青霉素噻唑蛋白抗体制备了青霉素G的免疫纳米金共振散射光谱探针。在pH5.4的柠檬酸-磷酸氢二钠缓冲溶液中,青霉素G与金标兔抗青霉素发生特异性结合生成胶体金免疫复合物,离心分离。取适量金标羊抗兔青霉素的上层清液做催化剂,在pH3.36盐酸-柠檬酸钠缓冲溶液－40μg/mL氯金酸－21.6μg/mL的盐酸羟胺条件下,进行催化反应后金纳米粒径增大,在580nm共振散射强度处增强。随着青霉素G浓度c增大,上层清液中免疫金纳米微粒数量降低,I580nm值降低。其降低值△I580nm与c在0.15-225 ng/mL范围内成线性关系,其回归方程为△I580nm=0.28c+5.16,检出限为0. 05 ng/mL。该法用于牛奶中青霉素G的检测,结果较好。     

A Facile Electrochemical Immunosensor with Mesoporous Alumina for Detection of Carcinoembryonic Antigen

A label‐free electrochemical immunosensor for the sensitive determination of carcinoembryonic antigen (CEA) was fabricated by immobilizing anti‐CEA onto mesoporous alumina (meso‐Al₂O₃) dispersed in chitosan (0.5 %wt) by the cross‐linking method using glutaraldehyde. Due to its plenty of active sites, meso‐Al₂O₃ showed high catalysis towards hydroquinone. With the electrocatalytic ability of meso‐Al₂O₃ for the reduction of hydroquinone, the current signal of the antigen‐antibody reaction was amplified and the enhanced sensitivity was achieved. The current decreased linearly with CEA concentration in the range of 0.04 to 10 ng/mL (26 pg/mL, S/N=3). The immunosensor had good selectivity and wonderful stability. Furthermore it was applied to the analysis of CEA in serum sample with satisfactory results.     

One‐Step Electrochemical Immunoassay for Carcinoembryonic Antigen in Human via Back‐Filling Immobilization of Gold Nanoparticles on DNA‐Modified Gold Electrodes

A new amperometric immunobiosensor for carcinoembryonic antigen (CEA) determination in human serum was developed via encapsulation of horseradish peroxidase‐labeled carcinoembryonic antibody (HRP‐anti‐CEA) in a gold nanoparticles/DNA composite architecture. The presences of gold nanoparticles provided a congenial microenvironment for the immobilized biomolecules and decreased the electron transfer impedance, leading to a direct electrochemical behavior of the immobilized HRP. The formation of the antibody–antigen complex by a simple one‐step immunoreaction between the immobilized HRP‐anti‐CEA and CEA in sample solution introduced a barrier of direct electrical communication between the immobilized HRP and the gold electrode surface. Under optimal conditions, the current change obtained from the labeled HRP relative to H₂O₂ system was proportional to the CEA concentration in two linear ranges from 0.5 to 15 ng/mL and 15 to 300 ng/mL with a detection limit of 0.1 ng/mL (at 3δ). The precision and reproducibility are acceptable with the intraassay CV of 6.3% and 4.7% at 8 and 60 ng/mL CEA, respectively. The storage stability of the proposed immunosensor is acceptable in a pH 7.0 PBS at 4 °C for 9 days. Moreover, the proposed immunosensors were used to analyze CEA in human serum specimens. Analytical results of clinical samples show the developed immunoassay has a promising alternative approach for detecting CEA in the clinical diagnosis.     

A Simple and Sensitive Label‐free Immunoassay for Factor B Using Resonance Scattering Spectral Detection

In pH 7.2 Na₂HPO₄‐NaH₂PO₄ buffer solution and in the presence of PEG‐6000, goat‐anti‐human factor B (GABF) was combined with human factor B (BF) specifically, and aggregated to form immune complex particles that exhibited a resonance scattering (RS) peak at 400 nm. The laser scattering indicated that the average diameter of immune complex particles was 1320 nm. BF in the concentration range of 0.04 to 9.60 µg/mL was proportional to the resonance scattering intensity at 400 nm. Its regression equation was ΔI=33.61C+ 1.4, with a correlation coefficient of 0.9969, and a detection limit of 0.01 µg/mL BF. This label‐free resonance scattering spectral (RSS) method has been applied to the determination of BF in serum samples, and the results were in agreement with that of the immunoturbity.     

Electro‐nano Diagnostic Platforms for Simultaneous Detection of Multiple Cancer Biomarkers

In this study, a bimetallic nanomaterial‐based electrochemical immunosensor was developed for the detection of carcinoembryonic antigen (CEA) and vascular endothelial growth factor (VEGF) cancer biomarkers at the same time. CEA and VEGF biomarkers are indicators for colon and breast cancers and stomach cancers, respectively. During the study, gold nanoparticle (AuNp), lead nanoparticle (PbNp), copper nanoparticle (CuNp) and magnetic gamma iron(III)oxide (γFe₂O₃ Np) were synthesized, characterized and used together for the first time in the structure of an electrochemical biosensor based on anti‐CEA and anti‐VEGF. For this purpose, Au SPE based sandwich immunosensor was fabricated by using labeled anti‐CEA (labeled with Pb⁺²) and labeled anti‐VEGF (labeled with Cu⁺²). As a result, CEA and VEGF biomarkers were detected following the oxidation peaks of label metals (Pb⁺² and Cu⁺²) by using differential pulse voltammetry. After the experimental parameters were optimized, the linear range was found in the concentration range between 25 ng/mL and 600 ng/mL with the relative standard deviation (RSD) value of (n=3 for 600 ng/mL) 3.33 % and limit of detection (LOD) value of 4.31 ng/mL for CEA biomarker. On the other hand, the linear range was found in the concentration range between 0.2 ng/mL and 12.5 ng/mL with the RSD value of (n=3 for 12.5 ng/mL) 5.31 % and LOD value of 0.014 ng/mL for VEGF biomarker. Lastly, sample application studies for synthetic plasma sample and interference studies with dopamine, ascorbic acid, BSA, cysteine and IgG were carried out.     

Resonance scattering spectral detection of ultratrace IgG using immunonanogold-HAuCl<Subscript>4</Subscript>-NH<Subscript>2</Subscript>OH catalytic reaction

Nanogold particles of 10 nm were used to label goat anti-human IgG (GIgG) to obtain nanogold-labeled GIgG (AuGIgG). In a citrate-HCI buffer solution of pH 2.27, AuGIgG showed a strong catalytic effect on the reaction between HAuCl₄ and NH₂OH to form big gold particles that exhibited a resonance scattering (RS) peak at 796 nm. Under the chosen conditions, AuGIgG combined with IgG to form immunocomplex AuGIgG-IgG that can be removed by centrifuging at 16000 r/min. AuGIgG in the centrifuging solution also showed catalytic effect on the reaction. On those grounds, an immunonanogold catalytic RS assay for IgG was designed. With addition of IgG, the amount of AuGIgG in the centrifuging solution decreased; the RS intensity at 796 nm (I _{796 nm}) decreased linearly. The decreased intensity ΔI _{796 nm} was linear with respect to the IgG concentration in the range of 0.08–16.0 ng · mL⁻¹ with a detection limit of 0.02 ng · mL⁻¹. This assay was applied to analysis of IgG in sera with satisfactory sensitivity, selectivity and rapidity. Supported by the National Natural Science Foundation of China (Grant No. 20667001), Natural Science Foundation of Guangxi Province (Grant No. 0728213), and the Foundation of New Century Ten-Hundred-Thousand Talents of Guangxi Province     

Amperometric sandwich-type aptasensor based on peroxidase mimetic Au@Pt for the carcinoembryonic antigen

For sensitive analysis of cancer biomarker carcinoembryonic antigen (CEA), an amperometric sandwich-type aptasensor is proposed based on a signal amplification strategy of Au@Pt bimetallic nanoprobes. As the excellent catalytic activity to hydrogen peroxide (H₂O₂), core-shell Au@Pt nanoparticles are employed as nanoprobes by conjugating directly with the secondary aptamer of CEA (Apt-II). Due to the synergic recognition effect of dual aptamers and the excellent catalytic activity of nanoprobes, this amperometric sandwich-type aptasensor for CEA exhibits high specificity and good sensitivity with a limit of detection of 0.31 ng/mL, along with a wide linear range from 0.1 ng/mL to 100 ng/mL.     

Electroanalytical Determination of Carcinoembryonic Antigen at a Silica Nanoparticles/Titania Sol–Gel Composite Membrane‐Modified Gold Electrode

A highly hydrophilic and nontoxic colloidal silica nanoparticle/titania sol–gel composite membrane was prepared on a gold electrode via a chemical vapor deposition method. With carcinoembryonic antigen (CEA) as a model antigen and encapsulation of carcinoembryonic antibody (anti‐CEA) in the composite architecture, this membrane could be used for reagentless electrochemical immunoassay. The presence of silica nanoparticles provided a congenial microenvironment for adsorbed biomolecules. The formation of immunoconjugate by a simple one‐step immunoreaction between CEA in sample solution and the immobilized anti‐CEA introduced the change in the potential. The modified procedure was further characterized by electrochemical impedance spectroscopy and cyclic voltammetry. Compared to the commonly applied methods, i.e., the TiO₂ direct embedding procedure, this strategy could allow for antibodies immobilized with higher loading amount and better retained immunoactivity. The resulting immunosensor exhibited high sensitivity, good precision, acceptable stability, accuracy, reproducibility and wide linear range from 1.5 to 240 ng mL^?1 with a detection limit of 0.5 ng mL^?1 at 3σ. Analytical results of clinical samples show that the developed immunoassay is comparable with the enzyme‐linked immunosorbent assays (ELISAs) method, implying a promising alternative approach for detecting CEA in the clinical diagnosis. Furthermore, this composite membrane could be used efficiently for the entrapment of other biomarkers and clinical applications.     

A highly sensitive and selective immunonanogold resonance scattering spectral assay for sudan I

A sensitive and selective resonance scattering spectral (RSS) assay was proposed for the determination of sudan I (SDI), using 10 nm nanogold to label the antibody against sudan I (anti-SDI Ab) to obtain a RSS probe for SDI. The immunonanogold reaction between nanogold-labelled anti-SDI Ab and SDI took place in pH 4.92 KH₂PO₄–Na₂HPO₄ buffer solution and in the presence of polyethylene glycol (PEG)-6000, and the intensity of resonance scattering peak at 580 nm decreased greatly. The decreased intensity ΔI_{580 nm} was proportional to the concentration of SDI in the range of 0.23–45.0 ng mL^?1. The linear regression equation was calculated as ΔI_580nm = 1.20c + 2.01 (R = 0.9975, n = 6), with a detection limit (3σ) of 0.13 ng mL^?1. The SDI in egg samples was assayed, with satisfactory results.     

Carbon Nanomaterials‐based Electrochemical Immunoassay with β‐Galactosidase as Labels for Carcinoembryonic Antigen

In this study, a novel signal‐amplified strategy for sensitive electrochemical sandwiched immunoassay of carcinoembryonic antigen (CEA) was constructed based on aminofunctionalized graphene oxide (GO‐NH₂) supported AgNPs used as catalytic labels of secondary anti‐CEA and β‐galactosidase (β‐Gal), Meanwhile, sulfhydrylation single‐wall carbon nanotubes (SWCNTs‐SH) as substrate materials embellished gold electrode through Au‐SH and connected with gold nanoparticles to form anti‐CEA/AuNPs/SWCNTs‐SH/Au sensing platform through layer‐by‐layer. In the presence of analyte CEA, a sandwich‐type immunoassay format was employed for determination of CEA by using the labeled β‐Gal toward the reduction of p‐aminophenyl galactopyranoside (PAPG) and the redox reaction of AgNPs. Under optimal conditions, the increase in the current was proportional to the concentration of CEA from 0.1 pg/mL to 200 ng/mL. The detection limit (LOD) was 0.036 pg/mL CEA at 3σ. The electrochemical immunoassay displayed an acceptable precision, selectivity, stability. Clinical serum specimens were assayed with the method, and the results were in acceptable agreement with those obtained from the referenced electrochemiluminescent method.